Apollomics Warrant Stock Today
| APLMW Stock | 0.03 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 83
|
Apollomics Warrant is selling for under 0.026 as of the 6th of January 2025; that is No Change since the beginning of the trading day. The stock's lowest day price was 0.026. Apollomics Warrant has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 7th of December 2024 and ending today, the 6th of January 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 26th of November 2021 | Category Healthcare | Classification Health Care |
Apollomics Warrant is entity of United States. It is traded as Stock on NASDAQ exchange. More on Apollomics Warrant
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Apollomics Stock Highlights
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Apollomics Warrant can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Apollomics Warrant's financial leverage. It provides some insight into what part of Apollomics Warrant's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Apollomics Warrant (APLMW) is traded on NASDAQ Exchange in USA. It is located in null and employs 59 people. Apollomics Warrant is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 25.09 M. Apollomics Warrant classifies itself under Biotechnology sector and is part of Health Care industry.
Apollomics Warrant generates negative cash flow from operations
Check Apollomics Warrant Probability Of Bankruptcy
Apollomics Warrant Historical Income Statement
Apollomics Stock Against Markets
Already Invested in Apollomics Warrant?
The danger of trading Apollomics Warrant is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Apollomics Warrant is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Apollomics Warrant. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Apollomics Warrant is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Apollomics Stock Analysis
When running Apollomics Warrant's price analysis, check to measure Apollomics Warrant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apollomics Warrant is operating at the current time. Most of Apollomics Warrant's value examination focuses on studying past and present price action to predict the probability of Apollomics Warrant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apollomics Warrant's price. Additionally, you may evaluate how the addition of Apollomics Warrant to your portfolios can decrease your overall portfolio volatility.